Millennium Management’s Biolase, Inc. BIOL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-116,664
| Closed | -$22.1K | – | 6722 |
|
|
2024
Q1 | $22.1K | Buy |
+116,664
| New | +$56.9K | ﹤0.01% | 5807 |
|
|
2023
Q3 | – | Sell |
-4,068
| Closed | -$28.8K | – | 6707 |
|
|
2023
Q2 | $28.8K | Buy |
+4,068
| New | +$68.1K | ﹤0.01% | 5582 |
|
|
2022
Q2 | – | Sell |
-80
| Closed | -$70K | – | 7672 |
|
|
2022
Q1 | $70K | Buy |
80
+34
| +74% | +$31.4K | ﹤0.01% | 6294 |
|
|
2021
Q4 | $45K | Sell |
46
-584
| -93% | -$737K | ﹤0.01% | 6508 |
|
|
2021
Q3 | $1.01M | Buy |
630
+618
| +5,150% | +$1.01M | ﹤0.01% | 4675 |
|
|
2021
Q2 | $21K | Sell |
12
-70
| -85% | -$130K | ﹤0.01% | 6429 |
|
|
2021
Q1 | $174K | Buy |
+82
| New | +$202K | ﹤0.01% | 5532 |
|
|
2020
Q4 | – | Sell |
-5
| Closed | -$4 | – | 5688 |
|
|
2020
Q3 | $4 | Buy |
+5
| New | +$4.69K | ﹤0.01% | 4379 |
|
|
2017
Q4 | – | Sell |
-4
| Closed | -$29K | – | 4152 |
|
|
2017
Q3 | $29K | Hold |
4
| – | – | ﹤0.01% | 3434 |
|
|
2017
Q2 | $53K | Sell |
4
-1
| -20% | -$14.8K | ﹤0.01% | 3359 |
|
|
2017
Q1 | $78K | Buy |
5
+4
| +400% | +$72.6K | ﹤0.01% | 3348 |
|
|
2016
Q4 | $25K | Buy |
+1
| New | +$19.8K | ﹤0.01% | 3275 |
|
|
2015
Q1 | – | Sell |
-2
| Closed | -$80K | – | 4221 |
|
|
2014
Q4 | $80K | Hold |
2
| – | – | ﹤0.01% | 3794 |
|
|
2014
Q3 | $56K | Buy |
+2
| New | +$56.6K | ﹤0.01% | 3591 |
|
Other funds holding BIOL
Millennium Management's BIOL Position: Q2 2024 in Review
Millennium Management sold out of Biolase, Inc. (BIOL) in Q2 2024, closing a stake of 116,664 shares — an estimated $22.1K sold.
Millennium Management first reported a position in BIOL in Q3 2014 and held it in 14 quarters. The position peaked at $1.01M in Q3 2021. 2 funds tracked by Wall St. Rank hold BIOL as of Q2 2024.
- Millennium Management reported no remaining Biolase, Inc. position as of Q2 2024 after selling out during the quarter.
- Millennium Management sold 116,664 Biolase, Inc. shares in Q2 2024, an estimated $22.1K.
- Millennium Management first reported a position in Biolase, Inc. in Q3 2014 and held it in 14 quarters.
- Millennium Management's Biolase, Inc. position peaked at $1.01M in Q3 2021.
- 2 funds tracked by Wall St. Rank held Biolase, Inc. as of Q2 2024.
Based on Millennium Management's 13F filing for Q2 2024, filed 14 Aug 2024.